Literature DB >> 15977097

IFN-gamma low production capacity in type 1 diabetes mellitus patients at onset of disease.

M A Avanzini1, L Ciardelli, E Lenta, A M Castellazzi, M Marconi, G Derosa, C Dos Santos, M Oliveri, A Pistorio, R Lorini, G d'Annunzio.   

Abstract

In type 1 diabetes mellitus (T1DM), cytokines can be directly cytotoxic to beta-cells, and/or play an indirect role influencing some cells of the immune system. Since several factors could impair cytokine serum levels, the purpose of our study was to longitudinally evaluate intracellular cytokines, in T1DM patients, and in subject at risk, by flow cytometry analysis. At T1DM onset we observed significantly lower percentage of peripheral CD4 + and CD8 + cells producing IFN-gamma in patients compared to controls and subjects at risk. The 15-month follow-up patients showed significantly lower percentage of CD4 + and CD8 + cells producing IFN-gamma compared to the other groups. At 8-year follow-up no significant differences were observed among the groups in the percentage of cells producing cytokines. We could have considered "exhausted cells" or these T cell subsets may be migrated from peripheral blood to pancreas. On the other hand, our results are in agreement with those reported in literature: in animal model the absence of IFN-gamma production makes beta-cells highly susceptible to viral infection and subsequent attack by natural killer cells, which lead to hyperglycaemia and diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15977097     DOI: 10.1055/s-2005-865643

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  5 in total

1.  Sepsis caused by Mycobacterium terrae complex in a patient with sickle cell disease.

Authors:  Ashwini K Esnakula; Sudhir K Mummidi; Patricia A Oneal; Tammey J Naab
Journal:  BMJ Case Rep       Date:  2013-05-02

2.  Immunological Basis for Rapid Progression of Diabetes in Older NOD Mouse Recipients Post BM-HSC Transplantation.

Authors:  Nan Wang; Narendiran Rajasekaran; Tieying Hou; Claudia Macaubas; Elizabeth D Mellins
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

3.  Immunomodulatory and Antidiabetic Effects of a New Herbal Preparation (HemoHIM) on Streptozotocin-Induced Diabetic Mice.

Authors:  Jong-Jin Kim; Jina Choi; Mi-Kyung Lee; Kyung-Yun Kang; Man-Jeong Paik; Sung-Kee Jo; Uhee Jung; Hae-Ran Park; Sung-Tae Yee
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-18       Impact factor: 2.629

Review 4.  T-cell exhaustion in immune-mediated inflammatory diseases: New implications for immunotherapy.

Authors:  Zhanyan Gao; Yang Feng; Jinhua Xu; Jun Liang
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

5.  Methylglyoxal modulates immune responses: relevance to diabetes.

Authors:  Claire L Price; Hafid O S Al Hassi; Nicholas R English; Alexandra I F Blakemore; Andrew J Stagg; Stella C Knight
Journal:  J Cell Mol Med       Date:  2009-06-16       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.